Multipoint pacing is associated with reduction of heart failure hospitalizations or death in patients who do not respond to cardiac resynchronization therapy: results of the MORE-CRT MPP randomized trial
Europace · 2025
DOI: 10.1093/europace/euaf070 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Europace, 2025. Verfasst von Christophe Leclercq und 14 weiteren Autor:innen. Beteiligte Einrichtung: Service de Cardiologie et Maladies Vasculaires, rue Henri le Guilloux 35033 Rennes Cédex 09, CHRU Hopital de Pontchaillou, Rennes, France. Hauptthemen laut MEDLINE: Heart Failure, Cardiac Resynchronization Therapy, Hospitalization. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott Medical Optics.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
Cardiac resynchronization therapy (CRT) via biventricular pacing (BIVP) is an effective treatment, but non-responders are at a higher risk of death and heart failure (HF) hospitalizations compared with CRT responders. The MORE-CRT MPP trial aimed to evaluate whether CRT with multipoint pacing (MPP) is associated with improved clinical outcomes in CRT non-responders. Methods and results Cardiac resynchronization therapy patients were treated with conventional BIVP for 6 months and then assessed for CRT response (left ventricular end-systolic volume relative reduction >15% vs. baseline). Cardiac resynchronization therapy non-responders were 1:1 randomized to BIVP or MPP and followed for 6 months. The main endpoint of this secondary analysis was HF hospitalizations or all-cause mortality. Of 3724 CRT patients (67 ± 11 years, 1050 female), 1677 were non-responders and randomized to MPP or BIVP, of whom 1421 (722 MPP and 699 BIVP) had complete data. In a mean follow-up of 5 ± 1 months after randomization, MPP was associated with a lower incidence of HF hospitalizations or all-cause mortality [48/722 (6.64%)] compared with BIVP (73/699 (10.44%), RRR = 36% (95% CI=±4%), P = 0.0107). At multivariable analysis, MPP was associated with a lower occurrence of the main endpoint (odds ratio = 0.60, P = 0.0124). At logistic regression analysis, HF hospitalizations or all-cause death were lower with MPP vs. BIVP in the whole population and in many patients subgroups, e.g. ischaemic patients and patients with long (>105 ms) interventricular electrical delay.
Conclusion
In the MORE-CRT MPP randomized trial, MPP was associated with a significant reduction of all-cause mortality and HF hospitalizations in prior non-responders to conventional biventricular pacing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service de Cardiologie et Maladies Vasculaires, rue Henri le Guilloux 35033 Rennes Cédex 09, CHRU Hopital de Pontchaillou, Rennes, France.
- Département de Cardiologie, Hôpital Cantonal Universitaire de Geneva, Geneva, Switzerland.
- Department of Cardiology, Policlinico Casilino, Rome, Italy.
- Department of Cardiology, St. Thomas' Hospital, London, UK.
- Department of Cardiology, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany.
- Département de Cardiologie, Institut de Cardiologie de Montreal, Montreal, Canada.
ORCID-Profile: Christophe Leclercq, Haran Burri, Leonardo Calò, Christopher Aldo Rinaldi, Johannes Sperzel, Bernard Thibault, Tim Betts, Pascal Defaye, Olivier Piot, Andrea Grammatico, Giuseppe Boriani
Förderung
- Abbott Medical Optics
Zitieren
APA
Leclercq, C., Burri, H., Calò, L., Rinaldi, C. A., Sperzel, J., Thibault, B., Betts, T., Defaye, P., Hain, A., Piot, O., Lee, K., Lin, W., Pollastrelli, A., Grammatico, A., & Boriani, G. (2025). Multipoint pacing is associated with reduction of heart failure hospitalizations or death in patients who do not respond to cardiac resynchronization therapy: results of the MORE-CRT MPP randomized trial. Europace. https://doi.org/10.1093/europace/euaf070
Vancouver
Leclercq C, Burri H, Calò L, Rinaldi CA, Sperzel J, Thibault B, et al. Multipoint pacing is associated with reduction of heart failure hospitalizations or death in patients who do not respond to cardiac resynchronization therapy: results of the MORE-CRT MPP randomized trial. Europace. 2025. doi:10.1093/europace/euaf070
BibTeX
@article{Leclercq2025,
author = {Leclercq, Christophe and Burri, Haran and Calò, Leonardo and Rinaldi, Christopher Aldo and Sperzel, Johannes and Thibault, Bernard and Betts, Tim and Defaye, Pascal and Hain, Andreas and Piot, Olivier and Lee, Kwangdeok and Lin, Wenjiao and Pollastrelli, Annalisa and Grammatico, Andrea and Boriani, Giuseppe},
title = {Multipoint pacing is associated with reduction of heart failure hospitalizations or death in patients who do not respond to cardiac resynchronization therapy: results of the MORE-CRT MPP randomized trial},
journal = {Europace},
year = {2025},
doi = {10.1093/europace/euaf070}
}
EUVIMED